• Nabriva initiates phase II of pleuromutilin antibiotic BC-3781

    2 June 2010
    Download

  • Mpex Pharmaceuticals presents positive phase 2 clinical trial results of Aeroquin (MP-376) treatment in Cystic Fibrosis patients

    17 May 2010
    Download

  • FDA Advisory Committee to review Lux Biosciences' Uveitis candidate Luveniq

    11 May 2010
    Download

  • Asthmatx receives FDA approval for the Alair Bronchial Thermoplasty System

    27 April 2010
    Download

  • Interventional Spine announces first US implant of RENEW for lumbar spinal stenosis

    19 April 2010
    Download

  • Lux Biosciences Luveniq receives FDA priority review

    30 March 2010
    Download

  • Anthera Pharmaceuticals completes Initial Public Offering

    4 March 2010
    Download

  • Abbott and Enanta announce advancement of Hepatitis C collaboration

    2 March 2010
    Download

  • Lux Biosciences files for Luveniq approval in US and Europe for noninfectious Uveitis

    4 February 2010
    Download

  • Kolltan Pharmaceuticals closes $ 10 million series B related financing

    20 January 2010
    Download

  • Asthmatx pivotal trial manuscript for Bronchial Thermoplasty published in the American Journal of Respiratory and Critical Care Medicine

    12 January 2010
    Download

  • GSK exercises option to progress development of ChemoCentryx's Traficet-EN for the treatment of inflammatory bowel diseases

    11 January 2010
    Download

  • ChemoCentryx's Traficet-EN demonstrates effectiveness in Crohn's disease

    7 December 2009
    Download

  • Nereus Pharmaceuticals presents positive study of randomized phase 2 clinical trial of Plinabulin (NPI-2358) in non-small cell lung cancer

    23 November 2009
    Download

  • Biovitrum - The creation of a new niche specialty pharmaceutical company focused on rare diseases - with strong cash flow generation and growth potential

    5 November 2009
    Download

  • Probiodrug closes series B financing round exceeding Euro 36 million (USD 54 million)

    2 November 2009
    Download

  • Nabriva Therapeutics raises Euro 15 million (USD 22 million)

    28 October 2009
    Download

  • Asthmatx receives FDA advisory panel recommendation for 'approvable with conditions' for bronchial thermoplasty with the Alair system for severe Asthma

    28 October 2009
    Download

  • PTC Therapeutics initiates phase 2 clinical trial of Ataluren (PTC124) in patients with Hemophilia

    26 October 2009
    Download

  • Lux Biosciences's potential of LUVENIQ (LX211) as first disease modifying treatment for sight-threatening non-infectious Uveitis highlighted at American Academy of Ophthalmology

    26 October 2009
    Download

  • Lux Biosciences completes $50 million series B financing

    19 October 2009
    Download

  • Paratek Pharmaceuticals signs worldwide license and commercialization agreement for PTK 0796, broad-spectrum oral and IV antibiotic in phase 3

    8 October 2009
    Download

  • mtm laboratories extends series C financing round by EUR 7 million bringing total to EUR 39 million (USD 57 million)

    5 October 2009
    Download

  • Sloning closes growth financing round led by LBBW Venture

    25 September 2009
    Download

  • Mpex Pharmaceuticals announces positive phase 2b clinical trial results with Aeroquin (MP-376) treatment in Cystic Fibrosis patients

    20 September 2009
    Download
    • More news